Rapid Micro Biosystems (NASDAQ:RPID) Announces Earnings Results

Rapid Micro Biosystems (NASDAQ:RPID) announced its earnings results on Friday. The company reported ($0.22) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.22), Zacks reports. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Stock Down 20.2 %

NASDAQ RPID traded down $0.67 during trading hours on Friday, reaching $2.64. The company’s stock had a trading volume of 8,097,076 shares, compared to its average volume of 626,480. The company has a market capitalization of $113.61 million, a price-to-earnings ratio of -2.34 and a beta of 1.25. Rapid Micro Biosystems has a 1 year low of $0.58 and a 1 year high of $4.04. The firm’s 50-day moving average price is $1.91 and its 200-day moving average price is $1.29.

Wall Street Analysts Forecast Growth

Separately, KeyCorp started coverage on Rapid Micro Biosystems in a report on Wednesday, February 12th. They issued an “overweight” rating and a $8.00 target price on the stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.